Physicians
Launch of the first FDA-approved technology in Iran to diagnose HPV (u...
Nilou Laboratory hereby announces the launch of Cobas HPV DNA Testing technology as the first FDA (F
Errors in POCT (Point of Collection Testing) and alternative site test...
In the literature, data on errors in POCT are scarce, the main focus being on analytic errors.
First-Trimester Contingent Screening for Trisomy 21 by Fetal Nuchal Tr...
Analysis of cell-free DNA in maternal blood has been proposed as a novel screening method for e
Human papilloma virus (HPV) genotypes concordance between Iranian coup...
Background: Human Papilloma Virus (HPV) genotypes concordance among sexual couples has been evaluate
Some Points about Serum biochemistry in prenatal screening
- In trisomy 21 free ß-hCG is higher than in euploid pregnancies and the difference between the two
Some points about the Nuchal Translucency in Ultrasound according to F...
Interpretation of Mixture model in NT
Non-invasive prenatal test to screen common trisomies in twin pregnanc...
Recent years have witnessed a shift from invasive methods of prenatal screening to non-invasive stra
New Findings on the Use of Fibrinogen in Gynecological Diseases
Fibrinogen is a blood-soluble protein that is converted to insoluble fibrin by the release of the th
Fine-tuning of routine combined first- trimester screening
Fine-tuning of routine combined first- trimester screening: program, a retrospective cohort study in
The decision to discontinue home isolation should be made in the conte...
The decision to discontinue home isolation should be made in the context of local circumstances.
Coronavirus and Laboratory Quality
I have a longstanding blog "Making Medical Lab Quality Relevant", a place where I get to express my
Interpretation of Mixture model in NT
Interpretation of Mixture model in NT